..to issue the public statement & take on that BS libelous article. This could actually end higher today, as they expressed confidence in the data from their onoing drug trials, and said there were no plans for a secondary.
Superforce... I agree with your comment, but I can't see where they say there are no plans for a secondary. In fact, I would not surprised if they did do a secondary. Nor would I really be too disappointed depending upon the deal/circumstances, firms involved, pricing, etc. at any rate ... Did I miss something? Did they say no funding plans?